Scientific Officer and Executive Director BioAgilytix Durham, North Carolina
Join Lynn Kamen and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “Advances in Bioanalysis to Support Rapid Drug Development”, that she is especially excited about.
T0930-06-34 Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA, Abbas Kabir, BioAgilytix
M0930-06-36 1-Tiered Approach for Anti-drug Antibody Testing in Clinical Study, Jessica (Zheng) Wang, Ph.D., Regeneron Pharmaceuticals
T1430-06-36Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody, Saskia Van Der Lee, Ph.D., Genmab
W0930-10-55 Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF, Dustin L. Miller, MS, Eli Lilly and Company
T1530-02-08 Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials, Md Mahmudul Hasan, Ph.D., Moderna, Inc.
